Greenland Capital Management »

Cerevel Therapeutics Hldng I shares owned by Greenland Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Greenland Capital Management from 13F filings

Historical chart of Greenland Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Greenland Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Greenland Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $379k 9.0k 42.27

More positions owned by Greenland Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr U.s. Real Es Etf Call Option (IYR)
Hess (HES)
PPL Corporation (PPL)
Select Sector Spdr Tr Indl (XLI)
Alliant Energy Corporation (LNT)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Vaneck Etf Trust Semiconductr Etf (SMH)
Amazon (AMZN)
Consolidated Edison (ED)
Booking Holdings (BKNG)
MercadoLibre (MELI)

View all positions for Greenland Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Qube Research & Technologies
Farallon Capital Management
Melqart Asset Management
Goldman Sachs Group
P. Schoenfeld Asset Management
Water Island Capital
Squarepoint Ops
Balyasny Asset Management
Hsbc Holdings
Morgan Stanley

View all funds holding Cerevel Therapeutics Hldng I